EA009417B1 - Производные 4-(2-фенилоксифенил)пиперидина или -1,2,3,6-тетрагидропиридина в качестве ингибиторов обратного захвата серотонина - Google Patents

Производные 4-(2-фенилоксифенил)пиперидина или -1,2,3,6-тетрагидропиридина в качестве ингибиторов обратного захвата серотонина Download PDF

Info

Publication number
EA009417B1
EA009417B1 EA200501580A EA200501580A EA009417B1 EA 009417 B1 EA009417 B1 EA 009417B1 EA 200501580 A EA200501580 A EA 200501580A EA 200501580 A EA200501580 A EA 200501580A EA 009417 B1 EA009417 B1 EA 009417B1
Authority
EA
Eurasian Patent Office
Prior art keywords
phenyl
piperidine
compound according
alkyl
hydrogen
Prior art date
Application number
EA200501580A
Other languages
English (en)
Russian (ru)
Other versions
EA200501580A1 (ru
Inventor
Бенни Банг-Андерсен
Фридрих Кролл
Ян Келер
Original Assignee
Х. Лундбекк А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36701494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA009417(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Х. Лундбекк А/С filed Critical Х. Лундбекк А/С
Priority claimed from PCT/DK2004/000241 external-priority patent/WO2004087155A1/en
Publication of EA200501580A1 publication Critical patent/EA200501580A1/ru
Publication of EA009417B1 publication Critical patent/EA009417B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
EA200501580A 2003-04-04 2004-04-02 Производные 4-(2-фенилоксифенил)пиперидина или -1,2,3,6-тетрагидропиридина в качестве ингибиторов обратного захвата серотонина EA009417B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300519 2003-04-04
PCT/DK2004/000241 WO2004087155A1 (en) 2003-04-04 2004-04-02 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
EA200501580A1 EA200501580A1 (ru) 2006-04-28
EA009417B1 true EA009417B1 (ru) 2007-12-28

Family

ID=36701494

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501580A EA009417B1 (ru) 2003-04-04 2004-04-02 Производные 4-(2-фенилоксифенил)пиперидина или -1,2,3,6-тетрагидропиридина в качестве ингибиторов обратного захвата серотонина

Country Status (8)

Country Link
KR (1) KR20050119682A (xx)
CN (1) CN1767829A (xx)
AR (1) AR043966A1 (xx)
CL (1) CL2004000726A1 (xx)
EA (1) EA009417B1 (xx)
IS (1) IS7901A (xx)
UA (1) UA81469C2 (xx)
ZA (1) ZA200505031B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2470929C2 (ru) * 2008-06-23 2012-12-27 Инститьют Оф Фармаколоджи Энд Токсиколоджи Академи Оф Милитари Медикал Сайенсес П.Л.А. Чайна Аминосоединения и их медицинское применение
RU2515612C2 (ru) * 2008-11-14 2014-05-20 Тереванс, Инк. 4-[2-(2-фторфеноксиметил)фенил]пиперидиновые соединения

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104710345B (zh) * 2013-12-17 2017-09-05 江苏恩华药业股份有限公司 用于制备4‑（2‑（4‑甲基苯基硫基））苯基哌啶的化合物、其制备方法及应用
CN105348204B (zh) * 2015-11-18 2018-09-14 乳源瑶族自治县大众药品贸易有限公司 1-杂环基-2-(杂芳基硫基)苯衍生物及其使用方法和用途
CN105294554B (zh) * 2015-11-18 2017-11-07 乳源瑶族自治县大众药品贸易有限公司 苯基哌嗪衍生物及其使用方法和用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
WO2001027068A1 (en) * 1999-10-13 2001-04-19 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
WO2003029232A1 (en) * 2001-10-04 2003-04-10 H. Lundbeck A/S Phenyl-piperazine derivatives as serotonin reuptake inhibitors

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
WO2001027068A1 (en) * 1999-10-13 2001-04-19 Pfizer Products Inc. Biaryl ether derivatives useful as monoamine reuptake inhibitors
WO2003029232A1 (en) * 2001-10-04 2003-04-10 H. Lundbeck A/S Phenyl-piperazine derivatives as serotonin reuptake inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
L. MARTIN ET AL.: "Synthesis of Spiro'isobenzofuran-1(3H),4'piperidines! as Potential Central Nervous System Agents. Conformationally Mobile Analogues Derived by Furan Ring Opening", J. MED. CHEM., vol. 22, no. 11, 1979, pages 1347-1354, XP002286159, table I *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2470929C2 (ru) * 2008-06-23 2012-12-27 Инститьют Оф Фармаколоджи Энд Токсиколоджи Академи Оф Милитари Медикал Сайенсес П.Л.А. Чайна Аминосоединения и их медицинское применение
RU2515612C2 (ru) * 2008-11-14 2014-05-20 Тереванс, Инк. 4-[2-(2-фторфеноксиметил)фенил]пиперидиновые соединения

Also Published As

Publication number Publication date
CL2004000726A1 (es) 2005-05-20
ZA200505031B (en) 2006-09-27
CN1767829A (zh) 2006-05-03
KR20050119682A (ko) 2005-12-21
IS7901A (is) 2005-06-20
AR043966A1 (es) 2005-08-17
EA200501580A1 (ru) 2006-04-28
UA81469C2 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
EP1077940B1 (en) 4-phenylpiperidines for the treatment of pruritic dermatoses
US6020345A (en) Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
JPH07110850B2 (ja) 窒素含有複素環化合物のフルオロアルコキシベンジルアミノ誘導体
RU2099339C1 (ru) Производные пиперидина
RU2139857C1 (ru) Производные 3-(пиперидинил-1)-хроман-4,7-диола и 1-(4-гидроксифенил)-2-(пиперидинил-1)-алканола, фармацевтическая композиция и способ связывания nmda рецептора
KR20010031783A (ko) Ｐｄｅ4 억제제 중 인다졸에 의한 카테콜의 생등입체성치환을 기재로 하는 치료상 활성인 화합물
JP2008524252A (ja) Ｃｎｓ障害の処置のためのテトラヒドロイソキノリン化合物
JP2005537293A (ja) Ｎ−［フェニル（ピペリジン−２−イル）メチル］ベンズアミド誘導体、その製造法、およびその治療用途
JPH09512804A (ja) ５−ｈｔ１ｄアンタゴニストとして有用なビフェニルカルボキシアミド類
JP2002518327A (ja) セロトニン再取り込みインヒビター
JP5165578B2 (ja) イソキノリンおよびベンゾ［ｈ］イソキノリン誘導体、調製およびヒスタミンｈ３受容体のアンタゴニストとしてのこの治療上の使用
EP1635828B1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
RU2102392C1 (ru) Пиперидилметилзамещенные производные хромана и их соли с неорганическими кислотами
JP2002535365A (ja) 抗うつ性複素環化合物
EA009417B1 (ru) Производные 4-(2-фенилоксифенил)пиперидина или -1,2,3,6-тетрагидропиридина в качестве ингибиторов обратного захвата серотонина
CN117447385B (zh) 氘代的3-氨甲基-4-苯基哌啶-4-醇类化合物的制备及其用途
JPH09505274A (ja) 抗炎症剤、抗アレルギー剤および免疫変調剤としての４−アルキルアミノ−１−フェノキシアルキルピペリジン
ES2301979T3 (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la reabsorcion de serotonina.
JPH0730019B2 (ja) 抗コリン性薬剤
CN117447388B (zh) 氘代的4-苯基哌啶-4-醇类化合物的制备及其用途
JP2002020287A (ja) 窒素含有複素環式化合物のフルオロアルコキシベンジルアミノ誘導体の医薬的使用
KR100882366B1 (ko) 프로판-1,3-디온 유도체 또는 그의 염
JP2003514764A (ja) ５−ｈｔ１受容体アゴニストとしてのアリール−｛４−フルオロ−４−［（２−ピリジン−２−イルエチルアミノ）メチル］ピペリジン−１−イル）メタノン誘導体
EA010869B1 (ru) Производные 4-(2-фенилсульфанилфенил)пиперидина в качестве ингибиторов повторного поглощения серотонина
JPH08268949A (ja) ジフェニルメチレン誘導体

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU